Intracellular P-glycoprotein expression is associated with the intrinsic multidrug resistance phenotype in human colon adenocarcinoma cells

International Journal of Cancer

Volumn 87, Issue 5, 2000, Pages 615-628

  Meschini, Stefania ^a   Calcabrini, Annarica ^a   Monti, Elena ^b   Del Bufalo, Donatella ^c   Stringaro, Annarita ^a   Dolfini, Ersilia ^d   Arancia, Giuseppe ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF INSUBRIA   (Italy)

^c REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN P;

ARTICLE; CARCINOMA CELL; COLON ADENOCARCINOMA; CYTOSKELETON; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; GOLGI COMPLEX; HUMAN; HUMAN CELL; MOLECULAR CLONING; MULTIDRUG RESISTANCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; ATP-BINDING CASSETTE TRANSPORTERS; BLOTTING, WESTERN; COLONIC NEOPLASMS; CYTOSKELETAL PROTEINS; CYTOSKELETON; DOXORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, FLUORESCENCE; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; P-GLYCOPROTEIN; PHENOTYPE; PRECIPITIN TESTS; TUMOR CELLS, CULTURED; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0033868625     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000901)87:5<615::AID-IJC1>3.0.CO;2-4     Document Type: Article

References (40)

1. ALLEY, M.C., SCUDIERO, D.A., MONKS, A., HURSEY, M.L., CZERWINSKI, M.J., FINE., D.L., ABBOTT, B.J., MAYO, J.G., SHOEMAKER, R.H. and BOYD, M.R., Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay. Cancer Res., 48, 589-601 (1988).
2. ARANCIA, G., CALCABRINI, A., MESCHINI, S. and MOLINARI, A., Intracellular distribution of anthracyclines in drug resistant cells. Cytotechnology. 27, 95-111 (1998).
3. BALDINI, N., SCOTLANDI, K., SERRA, M., SHIKITA, T., ZINI, N., OGNIBENE, A., SANTI, S., FERRACINI, R. and MARALDI, N.M., Nuclear immunolocalization of P-glycoprotein in multidrug-resistant cell lines showing similar mechanisms of doxorubicin distribution. Europ. J. Cell Biol., 68, 226-239 (1995).
4. CHU, J.J., CHEN, K.D., LIN, Y.L., FEI, C.Y., CHIANG, A.S., CHIANG, C.D. and LAI, Y.K., Taxol induces concomitant hyperphosphorylation and reorganization of vimentin intermediate filaments in 9L rat brain tumor cells. J. Cell Biochem., 68, 472-483 (1998).
5. CIANFRIGLIA, M., WILLINGHAM, M.C., TOMBESI, M., SCAGLIOTTI, V., FRASCA, G. and CHERSI, A., P-glycoprotein mapping. I. Identification of a linear human-specific epitope in the 4th loop of the P-glycoprotein extracellular domain by MM4.17 murine monoclonal antibody to human multidrug-resistant cells. Int. J. Cancer, 56, 153-160 (1994).
6. COLE, S.P.C., BHARDWAJ, G., GERLACH, J.H., MACKIE, J.E., GRANT, C.E., ALMQUIST, K.C., STEWART, A.J., KURZ, E.U., DUNCAN, A.M.V. and DEELEY, R.G., Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science, 258, 1650-1654 (1992).
7. CONFORTI, G., CODEGONI, A.M., SCANZIANI, E., DOLFINI, E., DASDIA, T., CALZA, M., CANIATTI, M. and BROGGINI, M., Different vimentin expression in two clones derived from a human colocarcinoma cell line (LoVo) showing different sensitivity to doxorubicin. Brit. J. Cancer, 71, 505-511 (1995).
8. DOLFINI, E., DASDIA, T., PERLETTI, G., ROMAGNONI, M. and PICCININI, F., Analysis of calcium-dependent protein kinase-C isoenzymes in intrinsically resistant cloned lines of LoVo cells. Reversal of resistance by kinase inhibitor 1-(5-isoquinolinylsulfonyl)2-methylpiperazine. Anticancer Res., 13, 1123-1128 (1993).
9. DOLFINI, E., DASDIA, T., ARANCIA, G., MOLINARI, A., CALCABRINI, A., SCHEPER, R.J., FLENS, M.J., GARIBOLDI, M.B. and MONTI, E., Characterization of a clonal human colon adenocarcinoma line intrinsically resistant to doxorubicin. Brit. J. Cancer, 76, 67-76 (1997).
10. DOMAGALA, W., LASOTA, J., BARTOWIAK, J., WEBER, K. and OSBORN, M., Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth traction. Amer. J. Pathol., 136, 219-227 (1990a).
11. DOMAGALA, W., LESZEK, W., LASOTA, J., WEBER, K. and OSBORN, M., Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. Amer. J. Phatol., 137, 1059-1064 (1990b).
12. DONG, Z., WARD, N.E., FAN, D., GUPTA, K. and O'BRIAN, C.A., In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells. Mol. Pharmacol., 39, 563-569 (1992).
13. FLENS, M.J., IZQUIERDO, M.A., SCHEFFER, G.L., SCHROEIJERS, A.B., FRITZ, J.M., MEIJER, C.J.L.M., SCHEPER, R.J. and ZAMAN, G.J.R., Immunochemical detection of MRP in human multidrug-resistant tumor cells by monoclonal antibodies. Cancer Res., 54, 4557-4563 (1994).
14. GERVASONI, J.E. Jr., FIELDS, S.Z., KRISHNA, S., BAKER, M.A., ROSADO, M., THURAISAMY, K., HINDENBURG, A.A. and TAUB, R.N., Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell line using laser-assisted confocal microscopy. Cancer Res., 51, 4955-4963 (1991)
15. GOTTESMAN, M.M. and PASTAN, I., Biochemistry of multidrug resistance mediated by the multidrug transporter. Ann. Rev. Biochem., 62, 385-427 (1993).
16. GRANDI, M. GERONI, C. and GIULIANI, G.C., Isolation and characterization of a human colon adenocarcinoma cell line resistant to doxorubicin. Brit. J. Cancer, 54, 515-518 (1986).
17. 1 190,000 multidrug resistance protein. MRP, with monoclonal antibodies. Cancer Res., 54, 5788-5792 (1994).
18. HO, D.T. and ROBERGE, M., The antitumor drug fostriecin induces vimentin hyperphosphorylation and intermediate filament reorganization. Carcinogenesis, 5, 967-972 (1996).
19. IZQUIERDO, M.A., SCHEFFER, G.L., FLENS, M.J., SCHROEIJRS, A.B., VAN DER VALK, P. and SCHEPER, R.J., Major vault protein LRP-related multidrug resistance. Europ. J. Cancer, 32A, 979-984 (1996).
20. LA PORTA, C.A., DOLFINI, E. and COMOLLI, R., Inhibition of protein kinase C-alpha isoform enhances the P-glycoprotein expression and the survival of LoVo human colon adenocarcinoma cells to doxorubicin exposure. Brit. J. Cancer, 78, 1283-1287 (1998).
21. LAURENCOT, C.M., SCHEFFER, G.L., SCHEPER, R.J. and SHOEMAKER, R.H., Increased LRP mRNA expression is associated with the MDR phenotype in intrinsically resistant human cancer cell lines. Int. J. Cancer, 72, 1021-1026 (1997).
22. LEE, S.A., KARASZKIEWICZ, J.W. and ANDERSON, W.B., Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells. Cancer Res., 52, 3750-3759 (1992).
23. LOE, D.W., DEELEY, R.G. and COLE, S.P.C., Biology of multidrug resistance-associated protein. MRP1. Europ. J. Cancer, 32A, 945-957 (1996).
24. MESCHINI, S., MOLINARI, A., CALCABRINI A., CITRO, G. and ARANCIA, G., Intracellular localization of the antitumor drug adriamycin in living cultured cells: a confocal microscopy study. J. Microsc., 176, 204-210 (1994).
25. MOLINARI, A., CIANFRIGLIA, M., MESCHINI, S., CALCABRINI, A. and ARANCIA, G., P-glycoprotein expression in the Golgi apparatus of multidrug-resistant cells. Int. J. Cancer, 59, 789-795 (1994).
26. MOLINARI, A., CALCABRINI, A., MESCHINI, S., STRINGARO, A., DEL BUFALO, D., CIANFRIGLIA, M. and ARANCIA, G., Detection of P-glycoprotein in the Golgi apparatus of drug-untreated human melanoma cells. Int. J. Cancer, 75, 885-893 (1998).
27. MONTI, E., PERLETTI, G., BROGGINI, M., DASDIA, T. and DOLUNI, E., Characterization of acquired and spontaneous resistance to doxorubicin in LoVo cells. Proc. Amer. Assoc. Cancer Res., 34, 24 (1993).
28. MORAN, E., CLEARY, I., LARKIN, A.M., NIC AMHLAOIBH, R., MASTERSON, A., SCHEPER, R.J., IZQUIERDO, M.A., CENTER, M., O'SULLIVAN, F. and CLYNES, M., Co-expression of MDR-associated markers, including P-170, MRP1 and LRP and cytoskeletal proteins, in 3 resistant variants of the human ovarian carcinoma cell line. OAW42. Europ. J. Cancer, 33, 652-660 (1997).
29. PASTAN, I. and GOTTESMAN, M.M., Multiple-drug resistance in human cancer. N. Eng. J. Med., 316, 1388-1393 (1987).
30. ROME, L., KEDERSHA, N. and CHUGANI, D., Unlocking vaults: organelles in search of a function. Trends Cell Biol., 1, 47-50 (1991).
31. RUTHERFORD, A.V. and WILLINGHAM, M.C., Ultrastructural localization of daunomycin in multidrug resistant cells with modulation of the multidrug transporter. J. Histochem. Cytochem., 41, 1573-1577 (1993).
32. SAEKI, T., UEDA, K., TANIGAWARA, Y., HORI, R. and KOMANO, T., Human P-glycoprotein transport cyclosporin A and FK506. J. Biol. Chem., 268, 6077-6080 (1993).
33. SCHEFFER, G.L., WIJNGARD, P.L.J., FLENS, M.J., IZQUIERDO, M.A., SLOVACK, M.L., PINEDO, H.M., MEIJER, C.J.L.M., CLEVERS, H.C. and SCHEPER, R.J., The drag resistance-related protein LRP is the human major vault protein. Nature Med., 1, 578-582 (1995).
34. 1 110,000 vesicular protein in non-P-glycoprotein-mediated multidrug resistance. Cancer Res., 53, 1475-1479 (1993).
35. SHAPIRO , A.B., FOX, K., LEE, P., YANG, Y.D. and LING, V., Functional intracellular P-glycoprotein. Int. J. Cancer, 76, 857-864 (1998)
36. SHAPIRO, A.B. and LING, V., Using purified P-glycoprotein to understand multidrug resistance. J. Bioenerg. Biomembr., 27, 7-13 (1995).
37. SOMMERS, C.L., HECKFORD, S.E., SKERKER, J.M., WORLAND, P., TORRI, J.A., THOMPSON, E.W., BYERS, S.W. and GELMANN, E.P., Loss of epithelial markers and acquisition of vimentin expression in adriamycin- and vinblastine-resistant human breast cancer cell lines. Cancer Res., 52, 5190-5197 (1992).
38. STEINERT, P.M., and ROOP, D.R., Molecular and cellular biology of intermediate filaments. Ann. Rev. Biochem., 57, 593-625 (1988).
39. WILLINGHAM, M.C., RICHERT, N.D., CORNWELL, M.M., TSURUO, T., HAMADA, H., GOTTESMAN, M.M. and PASTAN, I.H., Immunocytochemical localization of P170 at the plasma membrane of multidrug-resistant human cells. J. Histochem. Cytochem., 35, 1451-1456 (1987).
40. ZAMAN, G.J., FLENS, M.J., VAN LEUSDEN, M.R., DE HAAS, M., MULDER, H.S., LANKELMA, J. PINEDO, H.M., SCHEPER, R.J., BAAS, F., BROXTERMAN, H.J. and BURST, P., Role of glutathione in the export of compounds from cells by the multidrug resistance-associated protein. Proc. Natl. Acad. Sci. Wash., 91, 8822-8826 (1994).